Created in 1987 (United States), EpiTherapeutics own 32 sister brands and 17477 competing brands. The EpiTherapeutics brand is owned by Gilead Sciences, a company listed in New York. EpiTherapeutics is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Gilead Sciences
(EpiTherapeutics)
over 5 years*
USD 70.08